Monographie - Epirubicin hydrochloride

Cập nhật lần cuối :
19/11/2024

Epirubicin hydrochloride

Cấu trúc hóa học

Tên thương mại

Các tên thương mại được cung cấp và thành phần tá dược có thể khác nhau giữa các quốc gia và các hãng dược

Anthracine	Malaysia
Axirubicine	Đức
Bendaepi	Đức
Binarin	Mexico
Bioepycina	Ba Lan
Crisabon	Argentina
Cuatroepi	Argentina
Ecclepia	Romania
Elebicin	Mexico
Ellence	Hoa Kỳ
Epi Cell	Đức
Epidoxo	Argentina, Chile, Venezuela
Epifil	Ecuador
Epilem	Colombia, Mexico
Epimedac	Đức
Epirubicin	Ả Rập Saudi, Anh, Áo, Bỉ, Hungary, Iceland, new zealand, Thổ Nhĩ Kỳ, Thụy Sỹ, Thụy Điển, Úc, Đan Mạch
Epirubicina	Argentina, Colombia, Ecuador, Mexico, Romania, Tây Ban Nha
Epirubicine	Bỉ, Pháp, Thụy Sỹ
Farmarubicin	Thổ Nhĩ Kỳ
Farmorubicin	Ả Rập Saudi, Áo, Brazil, Hy Lạp, Na Uy, Phần Lan, Thụy Sỹ, Thụy Điển, Đan Mạch
Farmorubicin CSV	Cộng hòa Nam Phi
Farmorubicin PFS	Ba Lan, Croatia, Slovenia
Farmorubicin RD	Ba Lan, Brazil, Nga, Thụy Sỹ
Farmorubicin RTU	Hà Lan
Farmorubicina	Bồ Đào Nha, Brazil, Tây Ban Nha, Ý
Farmorubicine	Bỉ, Pháp
Pharmorubicin	Anh

Tài liệu tham khảo : Epirubicin hydrochloride

	Loại	Nguồn
148	Tạp chí	Dine T, Cazin JC, Gressier B, Luycks M, Brunet C, Cazin M, Goudaliez F, Mallevais ML, Toraub I. Stability and compatibility of four anthracyclines: doxorubicin, epirubicin, daunorubicin and pirarubicin with PVC infusion bags. Pharm Weekbl [Sci] 1992 ; 14: 365-369.
525	Tạp chí	De Vroe C, De Muynck C, Remon JP, Samsom M. A study on the stability of three antineoplastic drugs and on their sorption by IV delivery systems and end-line filters. Int J Pharm 1990 ; 65: 49-56.
683	Tạp chí	Walker SE, Lau DWC, DeAngelis C, Iazetta J, Coons C. Epirubicin stability in syringes and glass vials and evaluation of chemical contamination. Can J Hosp Pharm 1990 ; 43: 265-272.
686	Tạp chí	Wood MJ, Irwin WJ, Scott DK. Stability of doxorubicin, daunorubicin and epirubicin in plastic syringes and minibags. J Clin Pharm Ther 1990 ; 15: 279-289.
887	Tạp chí	Pujol M, Munoz M, Prat J, Giona V, De Bolos J. Stability study of epirubicin in NaCl 0.9% injection. Ann Pharmacotherapy 1997 ; 31: 992-995.
1237	Tạp chí	Keusters L, Stolk LML, Umans R, Van Asten P. Stability of solutions of doxorubicin and epirubicin in plastic minibags for intravesical use after storage at -20°C and thawing by microwave radiation. Pharm Weekbl [Sci] 1986 ; 8: 194-197.
1265	Tạp chí	Wood MJ, Irwin WJ, Scott DK. Photodegradation of doxorubicin, daunorubicin and epirubicin measured by high-performance liquid chromatography. J Clin Pharm Ther 1990 ; 15: 291-300.
1317	Tạp chí	Adams PS, Haines-Hutt RF, Bradford E, Palmer A, Rowland CG. Pharmaceutical aspects of home infusion therapy for cancer patients. Pharm J 1987 ; 238: 476-478.
1662	Tạp chí	Trissel LA, Saenz CA, Ingram DS, Ogundele AB. Compatibility screening of oxaliplatin during simulated Y-site administration with other drugs. J Oncol Pharm Practice 2002 ; 8: 33-37.
1823	Tạp chí	Sewell GJ, Rigby-Jones AE, Priston MJ. Stability of intravesical epirubicin infusion: a sequential temperature study. J Clin Pharm Ther 2003 ; 28: 349-353.
1897	Tạp chí	Sautou-Miranda V, Brigas F, Thibault M, Chopineau J. Compatibility of doxorubicin, daunorubicin and epirubicin with low-density polyethylene and polyvinyl chloride, and stability in various conditions of storage. EJHP 2001 ; 7, 3: 108-115.
1955	Tạp chí	Trissel LA, Zhang Y. Palonosetron HCl compatibility and stability with doxorubicin HCl and epirubicin HCl during simulated Y-site administration. Ann Pharmacotherapy 2005 ; 39: 280-283.
2168	Tạp chí	Ozdemir FA, Anilanmert B, Pekin M. Spectrophotometric investigation of the chemical compatibility of the anticancer irinotecan-HCl and epirubicin-HCl in the same infusion solution. Cancer Chemother Pharmacol 2005 ; 56, 5: 529-534.
2257	Thông tin của nhà sản xuất	Stability of epirubicin "Ebewe" infusion solutions. Ebewe Pharma 2007
3473	Tạp chí	Bennis Y, Savry A, Correard F, Montana M, Sauzet C, Gauthier-Villano L, Pisano P, Pourroy B. Stability of a highly concentrated solution of epirubicin for conventional transcatheter arterial chemoembolization. Int J Pharm 2015 ; 495, 2: 956-962.
3474	Thông tin của nhà sản xuất	Fluorouracil - Summary of Product Characteristics Accord Healthcare Limited 2009
3632	Thông tin của nhà sản xuất	Epirubicine (Epirubicine Hospira®) - Summary of Product Characteristics Hospira 2017
3670	Tạp chí	Sewell G, Massimini M. Studies on the stability and compatibility of cytotoxic drug infusion with the Tevadaptor system. EJOP 2014 ; 8, 3: 26-30.
3708	Poster	Sarakbi I, Thiesen J, Krämer I. Compatibility of epirubicin-loaded DC Beads with different contrast media. ECOP 2 Krakow 2014
3918	Tạp chí	Sarakbi I, Krämer I. Compatibility of epirubicin-loaded DC bead™ with different non-ionic contrast media. J Oncol Pharm Practice 2016 ; 22: 749-756.
4352	Tạp chí	Li J, Yao C, Xu Y, Ping P, Yin H, Sun Y. In vitro compatibility and stability of admixtures containing etoposide, epirubicin hydrochloride and vindesine sulphate in a single infusion bag. J Clin Pharm Ther 2019 ; 44: 875-882.

Mentions Légales